StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)

Close on Nov 16, 2026Market cap $6.07MP/E –Yield –

Biomerica enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Biomerica's enterprise value was $4.21M on Nov 11, 2026, against $3.62M a year earlier. Over the last 5 years it ranged from $1.38M to $49.54M, with a median of $6.86M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.21M+4.2%
2025Dec 31, 2025$4.04M+81.4%
2024Dec 31, 2024$2.23M-82.9%
2023Dec 29, 2023$13.04M-66.4%
2022Dec 30, 2022$38.84M-11.1%
2021Dec 31, 2021$43.67M-15.3%
2020Dec 31, 2020$51.56M+79.5%
2019Dec 31, 2019$28.73M+96.3%
2018Dec 31, 2018$14.64M-52.4%
2017Dec 29, 2017$30.75M+81.2%
2016Dec 30, 2016$16.97M+90.9%
2015Dec 31, 2015$8.89M+75.2%
2014Dec 31, 2014$5.07M+41.3%
2013Dec 31, 2013$3.59M-20.9%
2012Dec 31, 2012$4.54M+99.5%
2011Dec 30, 2011$2.28M–

More Biomerica figures

See a number that looks wrong?